Daniella Barber, DO
Internal Medicine · Englewood Cliffs, NJNPI 1700413168
Payments from drug & device makers
Across 113 payments — averaging $17.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$281
- Novo Nordisk$224
- Lilly USA, LLC$152
- Xeris Pharmaceuticals, Inc.$98
- UCB, Inc.$95
- Exact Sciences$86
- plus $1K from 26 others
What the payments were for
- Food & beverage$1,970100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 18 | $281 |
| Novo Nordisk | 13 | $224 |
| Lilly USA, LLC | 13 | $152 |
| Xeris Pharmaceuticals, Inc. | 6 | $98 |
| UCB, Inc. | 5 | $95 |
| Exact Sciences | 3 | $86 |
| GSK | 5 | $85 |
| Medtronic | 2 | $84 |
| Johnson & Johnson | 4 | $83 |
| Sanofi-aventis U.S. LLC | 4 | $79 |
| Bayer | 4 | $76 |
| Mannkind Corporation | 4 | $71 |
| Radius Health, Inc. | 4 | $69 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $49 |
| Pfizer | 3 | $48 |
| Corcept Therapeutics | 2 | $37 |
| Octapharma USA, Inc. | 2 | $36 |
| Boehringer Ingelheim | 2 | $34 |
| Lundbeck LLC | 2 | $34 |
| AbbVie | 2 | $33 |
| Aurinia Pharma U.S., Inc. | 1 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Abiomed | 1 | $19 |
| Ascendis Pharma Endocrinology Inc | 1 | $18 |
| Kowa Pharmaceuticals America, Inc. | 1 | $18 |
| Amphastar Pharmaceuticals, Inc. | 1 | $18 |
| IBSA Pharma Inc. | 1 | $17 |
| Currax Pharmaceuticals LLC | 1 | $16 |
| ANI Pharmaceuticals, Inc. | 1 | $16 |
| Invivyd Inc | 1 | $16 |
| AstraZeneca | 1 | $15 |
| Sobi, Inc | 1 | $15 |
How this compares
$1,970 in reported general payments places this provider in the 75th percentile of 4,032 internal medicine providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 59 | $607 |
| Rosuvastatin Calcium | 39 | $388 |
| Amlodipine Besylate | 63 | $351 |
| Ezetimibe | 15 | $300 |
| Gabapentin | 11 | $231 |
| Losartan Potassium | 27 | $203 |
| Levothyroxine Sodium | 21 | $184 |
| Pantoprazole Sodium | 15 | $175 |
| Metoprolol Succinate | 13 | $121 |
| Simvastatin | 12 | $118 |
| Metformin Hcl | 31 | $97 |
| Tamsulosin Hcl | 12 | $96 |
| Alendronate Sodium | 16 | $94 |
| Lisinopril | 16 | $93 |
| Alprazolam | 13 | $66 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Englewood Cliffs
- Sanjiv SharmaToms River$33.9M
- Jeffrey CarsonNew Brunswick$13.8M
- Samer HaddadHamilton$6.8M
- Magdy ShenoudaWall$3.7M
- Samar HameedLivingston$3.6M
- Jane RohlfTrenton$2.7M
- Mohammed NisarEdison$2.6M
- Michael CasserNew Milford$2.2M
- Sumitha ReddyHamilton$2M
- Helio PedroNewark$1.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.